Scottish Equity Partners
![]() |
|
| Industry | Private equity |
|---|---|
| Headquarters | Glasgow, Scotland |
| Key people | Calum Paterson, Managing Partner |
| Products | Venture Capital |
| Total assets | GBP £450 million |
| Employees | 25 |
| Website | http://www.sep.co.uk |
Scottish Equity Partners (or SEP) is a leading independent owner managed growth equity and venture capital firm. It invests in innovative, high growth companies in the information technology, healthcare and energy sectors. SEP typically invests between £5million and £15 million in growth companies and £2million to £10million in earlier stage venture opportunities either as sole investor or lead investor in syndication with others. SEP can invest in companies across the United Kingdom, and by exception, in Europe.
SEP funds are raised from global financial institutions, alternative asset management companies, pension funds, family offices and corporates.
Since its inception SEP has backed European technology companies including CSR plc, ip.access, BioVex, ARKeX, picoChip, MTEM, VirtenSys, Skyscanner and Gigle Networks.
Its healthcare and energy portfolio includes Cmed, Aridhia, Exco InTouch, CamSemi and Arkex
[edit] References
[edit] External links
- Scottish Equity Partners (company website)
|
|||||||||||||||||
